48 /100
MEDIUM RISK
Score updated Jul 14, 2026

MIST — Milestone Pharmaceuticals Inc. Dilution Risk Tracker

Track MIST dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MIST — Get alerts when the score changes →

As of July 14, 2026, Milestone Pharmaceuticals Inc. (MIST) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Milestone Pharmaceuticals Inc. has a market capitalization of $176.79M, 124.50M shares outstanding, 86 institutional holders tracked. Key dilution vectors include approximately 42 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
100
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
29%
🔁 Convertible Conversion 40%
• Significant convertible debt: 28% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split 30%
• 50-day avg $1.67 approaching $1 threshold
🔔 Track MIST — Get forecast alerts →

💹 Market Data

Market Cap$176.79M
Shares Outstanding124.50M
Float14.07M
Cash$184.22M
Debt$58.19M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 30.9% shares (2026Q1 vs prior)
86 institutional holders · 37.04M shares
#1 RTW INVESTMENTS, LP 6.33M shares
#2 MORGAN STANLEY 4.48M shares
#3 Propel Bio Management, LLC 4.12M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest12.60M
Days to Cover7.5
% of Float89.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for MIST Shareholders

Milestone Pharmaceuticals Inc. (MIST) has a DilutionScore of 48/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for MIST shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MIST in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MIST alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MIST Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MIST — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

AAT ACH AHRT ALOT AMPH

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MIST
📊 MIST FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MIST Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.